Baseline glutathione peroxidase activity affects prognosis after acute coronary syndromes
- PMID: 18941641
- PMCID: PMC2565519
Baseline glutathione peroxidase activity affects prognosis after acute coronary syndromes
Abstract
Oxidative stress is associated with atherosclerosis and plaque lesions in experimental in vitro models. Few in vivo studies have examined the association between redox status and the prognosis of acute coronary syndromes.We undertook a prospective, observational study of 137 patients who had been admitted because of an acute coronary syndrome. We determined glutathione peroxidase activity (a marker of systemic antioxidant status) and recorded clinical and angiographic features and cardiovascular events (cardiovascular death, reinfarction, readmission with a new ischemic event, or need for coronary revascularization).The mean age of the patients (78% of whom were men) was 61.7 +/- 10.9 years; 76% were admitted with non-ST-segment-elevation acute coronary syndrome. Left ventricular ejection fraction was normal in 61%. In the 23.4% who experienced cardiovascular events, glutathione peroxidase activity was higher (mean, 2.38 vs 1.76 mU/mg of protein; P < 0.01). Two-year event-free survival was lower in patients whose glutathione peroxidase activity was higher than the 50th percentile (63% vs 82%; P = 0.01). Multivariate analysis showed a direct independent relationship between glutathione peroxidase activity and cardiovascular events (hazard ratio, 3.72; 95% confidence interval, 1.53-9.02; P < 0.01).We conclude that patients who experienced acute coronary syndromes and events during follow-up had higher plasma glutathione peroxidase activity, and that glutathione peroxidase activity was an independent predictor of events during follow-up.
Keywords: Acute coronary syndromes; arteriosclerosis/etiology; biological markers/blood; glutathione peroxidase; oxidation-reduction; oxidative stress; prognosis.
Figures


Similar articles
-
Clinical and prognostic comparison between left ventricular transient dyskinesia and a first non-ST-segment elevation acute coronary syndrome.Coron Artery Dis. 2008 Nov;19(7):449-53. doi: 10.1097/MCA.0b013e32830eab74. Coron Artery Dis. 2008. PMID: 18923239
-
Relationship between ST-segment recovery and clinical outcomes after primary percutaneous coronary intervention: the HORIZONS-AMI ECG substudy report.Circ Cardiovasc Interv. 2013 Jun;6(3):216-23. doi: 10.1161/CIRCINTERVENTIONS.112.000142. Epub 2013 May 7. Circ Cardiovasc Interv. 2013. PMID: 23652600 Clinical Trial.
-
Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA-3 trials (FIR).Circulation. 2012 Jan 31;125(4):568-76. doi: 10.1161/CIRCULATIONAHA.111.061663. Epub 2011 Dec 23. Circulation. 2012. PMID: 22199015
-
[Non ST elevation acute coronary syndromes and normal coronary angiography: is it truly good news?].Ann Cardiol Angeiol (Paris). 2008 Nov;57(5):275-83. doi: 10.1016/j.ancard.2008.08.006. Epub 2008 Sep 17. Ann Cardiol Angeiol (Paris). 2008. PMID: 18930175 Review. French.
-
Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes.Mediators Inflamm. 2008;2008:135625. doi: 10.1155/2008/135625. Mediators Inflamm. 2008. PMID: 18382609 Free PMC article. Review.
Cited by
-
The LDL/HDL ratio predicts long-term risk of coronary revascularization in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: a cohort study.Braz J Med Biol Res. 2022 Feb 4;55:e11850. doi: 10.1590/1414-431X2021e11850. eCollection 2022. Braz J Med Biol Res. 2022. PMID: 35137855 Free PMC article.
-
Plasma metabolomics reveals a potential panel of biomarkers for early diagnosis in acute coronary syndrome.Metabolomics. 2014;10(3):414-424. doi: 10.1007/s11306-013-0595-9. Epub 2013 Oct 26. Metabolomics. 2014. PMID: 25814918 Free PMC article.
References
-
- Glass CK, Witztum JL. Atherosclerosis. the road ahead [sic]. Cell 2001;104(4):503–16. - PubMed
-
- Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342(3):154–60. - PubMed
-
- Steinberg D, Witztum JL. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation 2002;105(17):2107–11. - PubMed
-
- Blankenberg S, Rupprecht HJ, Bickel C, Torzewski M, Hafner G, Tiret L, et al.; AtheroGene Investigators. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med 2003;349 (17):1605–13. - PubMed
-
- Forgione MA, Cap A, Liao R, Moldovan NI, Eberhardt RT, Lim CC, et al. Heterozygous cellular glutathione peroxidase deficiency in the mouse: abnormalities in vascular and cardiac function and structure. Circulation 2002;106(9):1154–8. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials